ruxolitinib,niraparib,bevacizumab
gsk,takeda,novartis,janssen,incyte,roche
['niraparib', 'great job', 'gyn', 'brca', 'ruxolitinib']
oral abstracts #asco22 #gyncsm dr lengyl doing a great job reviewing niraparib, ruxolitinib , bev studies
* caution using niraparib in patients with no brca mutation *use ruxolitinib in maintenance setting?
*targeting vegf pathway in ccc 
#ovca survivor; research advocate; author; co-moderator #gyncsm chat;  #ASCO22 Feature Voice  COI: https://t.co/AUF1EprNVt Opinions are my own.